Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
11863 studies found for:    chemotherapy
Show Display Options
Download search resultsDownload the search results for:
chemotherapy (11863 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Unknown  Peri-operative Chemotherapy With ECX or XP in the Treatment of Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: Peri-operative chemotherapy of ECX;   Drug: Peri-operative chemotherapy of XP
2 Recruiting Outcomes in CRS/HIPEC as Initial Treatment of Ovarian, Fallopian Tube and Primary Peritoneal Cancer
Conditions: Stage III Ovarian Cancer;   Stage IV Ovarian Cancer;   Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Carcinoma;   Ovarian Carcinoma;   Fallopian Tube Carcinoma
Interventions: Procedure: Cytoreductive Surgery (CRS);   Drug: Adjuvant Chemotherapy;   Other: Questionnaire;   Procedure: Hyperthermic intraperitoneal chemotherapy;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Cisplatin
3 Unknown  Study of Neoadjuvant Chemotherapy of Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Neoadjuvant chemotherapy;   Drug: Chemotherapy
4 Not yet recruiting The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: One cycle TPF induction chemotherapy for NPC;   Drug: Three cycles TPF induction chemotherapy for NPC
5 Completed Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy
Condition: Non Small Cell Lung Cancer
Interventions: Radiation: radiation;   Other: Chemotherapy and radiotherapy;   Drug: Chemotherapy;   Other: Palliative radiotherapy and chemotherapy
6 Recruiting Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Adjuvant chemotherapy;   Procedure: Follow-up
7 Terminated NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent Chemoradiation
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: Adjuvant chemotherapy with paclitaxel and nedaplatin
8 Recruiting Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
Conditions: Adult Acute Myeloid Leukemia;   Adult Myelodysplastic Syndrome
Intervention: Drug: Chemotherapy
9 Not yet recruiting Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer
Condition: Colon Cancer
Interventions: Drug: Postoperative chemotherapy;   Drug: Neoadjuvant chemotherapy
10 Not yet recruiting Perioperative Chemotherapy VS Postoperative Chemotherapy for the Treatment of Colon Cancer With Resectable Liver Metastasis
Condition: Colon Cancer
Interventions: Drug: Peri-operative chemotherapy;   Drug: postoperative chemotherapy
11 Withdrawn Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases
Conditions: Metastatic Liver Cancer;   Secondary Liver Cancer;   Liver Neoplasm
Interventions: Device: Radiofrequency Ablation (RFA);   Drug: Chemotherapy
12 Recruiting Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy
Condition: Pancreatic Cancer
Interventions: Drug: Induction chemotherapy with gemcitabine or FOLFIRINOX;   Radiation: Radiotherapy, 28 x 1.8 Gy;   Drug: Chemotherapy, gemcitabine;   Drug: Chemotherapy with gemcitabine or FOLFIRINOX according to induction chemotherapy
13 Recruiting Safety Study Of Chemotherapy Combined With Dendritic Cell Vaccine to Treat Breast Cancer
Condition: Breast Cancer
Interventions: Biological: LA TNBC: DC vaccine+Preop chemo;   Biological: ER+/HER2-BC:DC vaccine+Preop chemo
14 Recruiting Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery
Conditions: Pancreatic Acinar Cell Carcinoma;   Pancreatic Ductal Adenocarcinoma;   Pancreatic Intraductal Papillary-Mucinous Neoplasm;   Stage IA Pancreatic Cancer;   Stage IB Pancreatic Cancer;   Stage IIA Pancreatic Cancer;   Stage IIB Pancreatic Cancer
Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy;   Drug: Capecitabine;   Drug: Chemotherapy;   Drug: Erlotinib Hydrochloride;   Drug: Fluorouracil;   Drug: Gemcitabine Hydrochloride;   Radiation: Intensity-Modulated Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment
15 Completed Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis
Condition: Colorectal Peritoneal Carcinomatosis
Interventions: Drug: Systemic chemotherapy alone (oxaliplatin, 5-fluorouracil, isovorin);   Procedure: Cytoreductive surgery (CRS) plus postoperative intraperitoneal chemotherapy (5-fluorouracil, isovorin)
16 Recruiting Clinical Study of Chemotherapy Combined With Chinese Medicine on Survival Affect of Elderly Patients With Lung Cancer
Condition: Cancer
Interventions: Drug: TCM;   Drug: Chemotherapy
17 Recruiting Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer
Conditions: Breast Cancer;   Adenocarcinoma of the Breast
Interventions: Radiation: PBI;   Other: PBI with chemotherapy
18 Active, not recruiting Intra-operative Chemotherapy With 5-FU for Colorectal Cancer Patients Receiving Curative Resection: Efficacy and Safety
Condition: Colorectal Cancer
Interventions: Procedure: curative resection for colorectal cancer;   Drug: intra-operative 5-FU chemotherapy
19 Recruiting Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Inductive chemotherapy + concurrent cisplatin and IMRT;   Drug: Inductive chemotherapy + IMRT
20 Completed Tandem Melphalan and Autolog. SCT in MM Patients 60 to 70 Years of Age With and Without Induction Chemotherapy
Condition: Multiple Myeloma
Interventions: Drug: Anthracycline/dexamethasone-based induction chemotherapy;   Drug: Dexamethasone for control of symptoms;   Drug: Tumor-reduction chemotherapy and stem cell mobilization;   Procedure: Stem cell apheresis;   Drug: Tandem high-dose chemotherapy (melphalan);   Procedure: Autologous peripheral blood stem cell transplantation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years